MicroCloud Hologram (HOLO), a tech company specializing in holographic technology and quantum blockchain security, has been in freefall, with ...
Additionally, Aclarion has announced a reverse stock split of its common stock at a ratio of 1-for-335, reducing the number of issued and outstanding shares from approximately 169.4 million to about ...
In a challenging year for Aclarion, the medical technology company's stock has plummeted to a 52-week low, trading at $4.41. According to InvestingPro data, the company maintains a healthy liquidity ...
Algorhythm (RIME) Holdings announced the date of effectiveness and the ratio of a forthcoming reverse stock split of the Company’s Common Stock. On January 13, 2025, the Company announced ...
Following the announcement, Info Edge share price rallied nearly 4%. The company said the stock split will enhance the liquidity of the company's shares and encourage the participation of retail ...
The reverse stock split will be effective for trading purposes as of the commencement of trading on February 5, 2025. The reverse stock split is intended to increase the per share trading price of ...
In a bid to maintain compliance with Nasdaq's listing standards, Aclarion executed a reverse stock split at a ratio of 1-for-335. This move resulted in the company's gross proceeds reaching ...
Aclarion secured $20 million in funding for its clinical trial of Nociscan. Nociscan is a diagnostic tool that aims to improve surgical outcomes for chronic low back pain patients. Get real-time ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results